New drug aims to keep new moms Opioid-Free after C-Section
NCT ID NCT07534709
First seen Apr 23, 2026 · Last updated Jun 09, 2026 · Updated 14 times
Summary
This study tests whether adding suzetrigine to standard pain management helps more women stay completely opioid-free for the first 72 hours after a C-section. About 90 women having scheduled or unscheduled C-sections will receive either suzetrigine or a placebo, along with usual pain medicines. Opioids will still be available if needed for severe pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas at Austin Dell Medical School, Department of Women's Health
Austin, Texas, 78705, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.